EKSO
Ekso Bionics·NASDAQ
--
--(--)
--
--(--)
EKSO fundamentals
Ekso Bionics (EKSO) released its earnings on Jul 28, 2025: revenue was 2.06M (YoY -58.44%), missed estimates; EPS was -1.24 (YoY +36.41%), beat estimates.
Revenue / YoY
2.06M
-58.44%
EPS / YoY
-1.24
+36.41%
Report date
Jul 28, 2025
EKSO Earnings Call Summary for Q2,2025
- Q2 Revenue Miss: $2.1M (-58% YoY) due to $1.4M deferred Enterprise Health sales, partially offset by 50% growth in Personal Health.
- Gross Margin Pressure: 40% vs. 53% YoY, driven by fixed costs and lower-margin distribution.
- AI & Education Push: Launched eksoUniversity and NVIDIA Connect program to accelerate exoskeleton adoption with AI voice control.
- Personal Health Momentum: 25% of 2025 revenue (vs. 10% in 2024), 45 Medicare beneficiaries in pipeline (+200% YoY).
- Risks: 10% of Enterprise customers reliant on federal grants; uncertain pipeline conversion rate.
EPS
Actual | -6.6 | -28.2 | 4.5 | -7.2 | -5.1 | -1.65 | -2.55 | -3.45 | -5.4 | -3.45 | -4.95 | -3.6 | -4.95 | -4.65 | -3.6 | -3.3 | -3 | -1.95 | -1.5 | -2.1 | -1.8 | -1.24 | |||||||||||
Forecast | -9.15 | -8.325 | -5.85 | -4.5 | -3.6 | -3.75 | -3.75 | -3.75 | -6.15 | -3.6 | -3.6 | -3.3 | -4.65 | -4.2 | -4.65 | -1.65 | -2.4 | -1.95 | -1.575 | -1.2 | -1.65 | -1.35 | |||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +27.87% | -238.74% | +176.92% | -60.00% | -41.67% | +56.00% | +32.00% | +8.00% | +12.20% | +4.17% | -37.50% | -9.09% | -6.45% | -10.71% | +22.58% | -100.00% | -25.00% | 0.00% | +4.76% | -75.00% | -9.09% | +8.15% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.47M | 2.26M | 2.90M | 2.25M | 1.91M | 2.21M | 3.05M | 4.08M | 2.57M | 3.46M | 3.33M | 3.55M | 4.12M | 4.70M | 4.61M | 4.85M | 3.76M | 4.95M | 4.13M | 5.09M | 3.38M | 2.06M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.41M | 1.62M | 2.45M | 2.58M | 3.00M | 2.14M | 2.58M | 2.76M | 3.20M | 3.49M | 3.58M | 3.94M | 2.80M | 4.40M | 4.50M | 4.80M | 5.00M | 5.15M | 5.55M | 5.05M | 4.62M | 4.31M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +4.41% | +39.84% | +18.46% | -12.70% | -36.33% | +3.32% | +18.32% | +47.57% | -19.78% | -0.83% | -7.09% | -9.78% | +47.21% | +6.89% | +2.38% | +0.98% | -24.88% | -3.88% | -25.60% | +0.79% | -27.02% | -52.30% |
Earnings Call
You can ask Aime
What does Ekso Bionics do and what are its main business segments?Did Ekso Bionics beat or miss consensus estimates last quarter?What were the key takeaways from Ekso Bionics's earnings call?What is Ekso Bionics's latest dividend and current dividend yield?What factors drove the changes in Ekso Bionics's revenue and profit?What is the market's earnings forecast for Ekso Bionics next quarter?What is Ekso Bionics's gross profit margin?What is the revenue and EPS growth rate for Ekso Bionics year over year?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
